Back
Compass Therapeutics, Inc. Stock Predictions
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now
Buy
55
CMPX
Compass Therapeutics, Inc.
Last Price:
$5.36
Seasonality Move:
2.61%
7 Day Trial
ALL ACCESS PASS
$
7
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist NowCompass Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Compass Therapeutics, Inc. has on average historically risen by 50.8% based on the past 4 years of stock performance.
-
Compass Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Compass Therapeutics, Inc. Stock Undervalued?The current Compass Therapeutics, Inc. [CMPX] share price is $5.53. The Score for CMPX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
CMPX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Compass Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Compass Therapeutics, Inc. has on average historically risen by 50.8% based on the past 4 years of stock performance.
Compass Therapeutics, Inc. Stock Rating
Buy
55
Compass Therapeutics, Inc. (CMPX)
is a Buy
Is Compass Therapeutics, Inc. overpriced?
-
Compass Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Compass Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
compasstherapeutics.com
52-Week Data
52-Week High:
5.86
52-Week Low:
1.33
Prediction Charts
Market Cap:
983.6M
Price in USD:
5.53
Volume:
1.1M
Beta:
1.26
Technical Analysis
SMA50:
4.37
SMA100:
3.79
SMA200:
3.03
52-Wk Change:
261.44%
Stock Predictions
-
Is Compass Therapeutics, Inc. stock public?Yes, Compass Therapeutics, Inc. is a publicly traded company.
-
What is the Compass Therapeutics, Inc. stock quote today?The Compass Therapeutics, Inc. stock price is 5.53 USD today.
-
How to buy Compass Therapeutics, Inc. stock online?You can buy Compass Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 4.87 | 4.89 | 5.06 | 4.77 |
| Nov-18 | 4.88 | 4.93 | 5.05 | 4.83 |
| Nov-19 | 4.93 | 4.90 | 5.11 | 4.90 |
| Nov-20 | 4.94 | 4.85 | 5.07 | 4.79 |
| Nov-21 | 4.85 | 4.87 | 5.00 | 4.81 |
| Nov-24 | 4.95 | 4.95 | 5.16 | 4.92 |
| Nov-25 | 4.99 | 5.01 | 5.03 | 4.73 |
| Nov-26 | 5.09 | 5.39 | 5.40 | 4.96 |
| Nov-28 | 5.51 | 5.80 | 5.85 | 5.45 |
| Dec-1 | 5.85 | 5.46 | 5.86 | 5.33 |
| Dec-2 | 5.60 | 5.22 | 5.65 | 5.13 |
| Dec-3 | 5.39 | 5.28 | 5.39 | 5.17 |
| Dec-4 | 5.25 | 5.54 | 5.61 | 5.25 |
| Dec-5 | 5.59 | 5.53 | 5.74 | 5.48 |
Compass Therapeutics, Inc. Earnings
Compass Therapeutics, Inc. Earnings Report: Per Share Compass Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Compass Therapeutics, Inc. Forecast Revenue Growth
Compass Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Compass Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.00 per share.
* Compass Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.